Similar articles

• Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size.

  Clark C, Foreman MI, Kane KA, McDonald FM, Parratt JR. Clark C, et al. J Pharmacol Methods. 1980 Jun;3(4):357-68. doi: 10.1016/0160-5402(80)90077-7. J Pharmacol Methods. 1980. PMID: 7392665
• The effects of prolonged oral administration of a new antidysrhythmic drug (Org 6001) on coronary artery ligation dysrhythmias in conscious and anesthetized rats.

  Kane KA, Leprán I, McDonald FM, Parratt JR, Szekeres L. Kane KA, et al. J Cardiovasc Pharmacol. 1980 Jul-Aug;2(4):411-23. doi: 10.1097/00005344-198007000-00008. J Cardiovasc Pharmacol. 1980. PMID: 6156339
• Comparative electrophysiological effects of Org 6001, a new orally active antidysrhythmic agent, and lignocaine on human ventricular muscle.

  Kane KA. Kane KA. Br J Pharmacol. 1980 Jan;68(1):25-31. doi: 10.1111/j.1476-5381.1980.tb10695.x. Br J Pharmacol. 1980. PMID: 7357199 Free PMC article.
• Comparative antidysrhythmic and haemodynamic effects of orally or intravenously administered mexiletine and ORG 6001 in the anaesthetized rat.

  Marshall RJ, Muir AW, Winslow E. Marshall RJ, et al. Br J Pharmacol. 1981 Oct;74(2):381-8. doi: 10.1111/j.1476-5381.1981.tb09982.x. Br J Pharmacol. 1981. PMID: 7317687 Free PMC article.
• The antidysrhythmic and cardiovascular effects of the aminosteroid, ORG 6001.

  Marshall RJ, Winslow E. Marshall RJ, et al. Gen Pharmacol. 1981;12(5):315-22. doi: 10.1016/0306-3623(81)90082-3. Gen Pharmacol. 1981. PMID: 7026350 Review. No abstract available.